UY39463A - Microsuspensión contra parásitos y método para obtenerla - Google Patents

Microsuspensión contra parásitos y método para obtenerla

Info

Publication number
UY39463A
UY39463A UY0001039463A UY39463A UY39463A UY 39463 A UY39463 A UY 39463A UY 0001039463 A UY0001039463 A UY 0001039463A UY 39463 A UY39463 A UY 39463A UY 39463 A UY39463 A UY 39463A
Authority
UY
Uruguay
Prior art keywords
microsuspension
against parasites
parasite
microns
animals
Prior art date
Application number
UY0001039463A
Other languages
English (en)
Inventor
Claudio Mascaro
Original Assignee
Ipanema Ind De Produtos Veterinarios Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipanema Ind De Produtos Veterinarios Ltda filed Critical Ipanema Ind De Produtos Veterinarios Ltda
Publication of UY39463A publication Critical patent/UY39463A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
    • A01N47/18—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, directly attached to a heterocyclic or cycloaliphatic ring
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P5/00—Nematocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Abstract

La presente invención se refiere a una microsuspensión contra parásitos en animales y su método de preparación, más particularmente dirigida a la industria veterinaria. La microsuspensión contra parásitos incluye lactona macrocíclica y sulfóxido de albendazol, y presenta un tamaño de partícula promedio de D50 = 250 micras.
UY0001039463A 2020-10-16 2021-10-08 Microsuspensión contra parásitos y método para obtenerla UY39463A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102020021181-1A BR102020021181A2 (pt) 2020-10-16 2020-10-16 Microssuspensão contra parasitas e método para sua obtenção

Publications (1)

Publication Number Publication Date
UY39463A true UY39463A (es) 2022-05-31

Family

ID=81207349

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039463A UY39463A (es) 2020-10-16 2021-10-08 Microsuspensión contra parásitos y método para obtenerla

Country Status (7)

Country Link
US (1) US20240000752A1 (es)
EP (1) EP4230203A1 (es)
AR (1) AR123832A1 (es)
AU (1) AU2021361343A1 (es)
BR (1) BR102020021181A2 (es)
UY (1) UY39463A (es)
WO (1) WO2022077087A1 (es)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915986A (en) 1974-06-19 1975-10-28 Smithkline Corp Methyl 5-propylthio-2-benzimidazolecarbamate
GB2025223A (en) 1978-07-17 1980-01-23 Syntex Inc Injectable anthelmintic benzimidazole compositions
NZ266408A (en) 1993-05-26 1997-09-22 Commw Scient Ind Res Org Antiparasitic, oral particulate composition for ruminants
EP0919231A1 (en) 1997-10-15 1999-06-02 Biogenesis, S.A. Injectable parasiticide composition and process for the preparation
NZ534939A (en) 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
KR20080073700A (ko) * 2005-12-06 2008-08-11 와이어쓰 벤즈이미다졸 비수성 조성물
EP2037914B1 (en) * 2006-06-14 2013-10-23 Intervet International BV A suspension comprising benzimidazole carbamate and a polysorbate
CN101984958B (zh) * 2010-11-01 2012-08-08 新疆医科大学第一附属医院 纳米级阿苯达唑微粉及其制备方法
NZ619290A (en) * 2010-12-08 2015-04-24 Jurox Pty Ltd Anthelmintic formulation
AU2013205280A1 (en) * 2012-04-19 2013-11-07 Alleva Animal Health Limited Macrocyclic Lactone injectable Formulations
BR102013031277B1 (pt) 2013-12-05 2018-10-02 Ouro Fino Participacoes E Empreendimentos S A processo para preparar uma suspensão anti-helmíntica e suspensão anti-helmíntica injetável
CN103800355A (zh) * 2014-02-26 2014-05-21 江苏斯威森生物医药工程研究中心有限公司 一种含伊维菌素、丙硫亚砜和吡喹酮复方长效微球驱虫药
BG2358U1 (bg) * 2016-03-23 2016-12-30 "Ендектовет" Еоод Антихелминтно средство
CN106389456B (zh) * 2016-11-16 2020-06-09 佛山市正典生物技术有限公司 一种兽用阿苯达唑伊维菌素预混剂及其制备方法
RU2732293C1 (ru) * 2019-11-26 2020-09-15 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. К.И. Скрябина и Я.Р. Коваленко" (ФГБНУ ФНЦ ВИЭВ РАН) Супрамолекулярный антигельминтный комплекс для лечения и профилактики животных при основных гельминтозах

Also Published As

Publication number Publication date
WO2022077087A1 (pt) 2022-04-21
BR102020021181A2 (pt) 2022-04-26
EP4230203A1 (en) 2023-08-23
AR123832A1 (es) 2023-01-18
AU2021361343A1 (en) 2023-06-08
US20240000752A1 (en) 2024-01-04

Similar Documents

Publication Publication Date Title
EP3481332A4 (en) FAST, REAL-TIME, LARGE DEPTH OF FIELD, MULTISPECTRAL BODY OPTICAL IMAGING FOR SKIN SURVEILLANCE AND PHOTOGRAPHY
WO2017093228A3 (en) Laser markable compositions and methods to manufacture a packaging therewith
BR112017014340A2 (pt) quitina, hidrolisado e método para a produção de um ou mais produtos desejados a partir de insetos por meio de hidrólise enzimática
MY194716A (en) Anthelmintic depsipeptide compounds
MX2017012848A (es) Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.
NZ734948A (en) Long-acting injectable formulations comprising an isoxazoline active agent, methods and uses thereof
BR112019007476A2 (pt) dispersão aquosa e usos da mesma
AR115599A1 (es) Método y aparato para la preparación de un bien de ensilado y proceso de ensilaje
UY39463A (es) Microsuspensión contra parásitos y método para obtenerla
CA3028338A1 (en) Microencapsulation of bacteriophages and related products
NZ701697A (en) Stable veterinary anthelmintic formulations
EP3673111A4 (en) FABRIC PRODUCT MADE FROM A LASER ENGRAVED TEXTURING TAPE
EP3511354A4 (en) AQUEOUS DISPERSION, METHOD FOR THE PRODUCTION THEREOF AND PICTURE PRODUCTION METHOD
CO2021009571A2 (es) Polvo de azufre micronizado
CR20150508A (es) Formulaciones veterinarias estables de combinación de lactonas macrocíclicas e imidazotiazoles
JP2017113780A5 (es)
CL2018001017A1 (es) Conservación de vitaminas hidrosolubles.
CU20190019A7 (es) Combinaciones que incluyen abx196 útiles en el tratamiento del cáncer
CR20130642A (es) Una composición antiparasitaria y método de tratamiento
AR108149A1 (es) Producto para el cuidado bucal
EP3451347A4 (en) RAY INTENSITY CONVERSION FILM AND METHOD FOR PRODUCING RADIANT INTENSITY FILM CONVERSION
IT201600131605A1 (it) Impianto di piccole dimensioni e procedimento ottimizzato per la preparazione di una soluzione acquosa di urea
IL283718A (en) Formulation of a sustained-release drug comprising an outer layer with an enzymatically degradable polymer, its preparation and method of production
BR112018001251A2 (pt) ?métodos e superfície interna ou externa?
CL2018000568A1 (es) Composición de piensos para la prevención y el tratamiento de infección parasitaria de peces